Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait

被引：0
|
作者：
Jasem AL-Hashel
Samar F. Ahmed
Raed Behbehani
Raed Alroughani
机构：
[1] Ibn Sina Hospital,Department of Neurology
[2] Kuwait University,Faculty of Medicine
[3] Minia University,Department of Neurology and Psychiatry
[4] Al-Bahar Eye Center,Department of Ophthalmology
[5] Dasman Diabetes Institute,Neurology Clinic
[6] Amiri Hospital,Division of Neurology, Department of Medicine
来源：
CNS Drugs | 2014年 / 28卷
关键词：
Multiple Sclerosis; Expand Disability Status Scale; Natalizumab; Glatiramer Acetate; Fingolimod;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：817 / 824
页数：7
相关论文
共 50 条
  • [21] Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait
    Alroughani, R.
    Al Hashel, J.
    Thussu, A.
    Ahmed, S. F.
    MEDICAL PRINCIPLES AND PRACTICE, 2013, 22 (05) : 495 - 499
  • [22] Argentinean registry of patients with relapsing remitting multiple sclerosis treated with fingolimod (REAL): design and results of interim analysis
    Seifer, G.
    Kuperman, G. A.
    Villa, A.
    Caceres, F.
    Herrera, G.
    Rey, R.
    Parada Marcilla, M.
    Calvo Vildoso, C.
    Arguello, G.
    Parisi, V.
    Neme, R.
    Sinay, V.
    Blasco, J. M.
    Labal, P.
    Burgos, M.
    Deri, N.
    Linares, R.
    Vetere, S.
    Jacobo, M.
    Golberg, M.
    Castronuovo, A.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 165 - 166
  • [23] Real-world outcomes of teriflunomide in relapsing–remitting multiple sclerosis: a prospective cohort study
    Yao Zhang
    Hexiang Yin
    Dingding Zhang
    Yan Xu
    Bin Peng
    Liying Cui
    Journal of Neurology, 2022, 269 : 4808 - 4816
  • [24] The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis
    Kotov, S. V.
    Fedorova, S. I.
    Yakushina, T. I.
    Lizhdvoy, V. Yu
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (02) : 74 - 78
  • [25] Real-World Experience in an Irish Centre using Cladribine in Patients with Relapsing-Remitting Multiple Sclerosis
    O'Donnell, Martin
    Pavalaghanthan, Hariesh
    Jose, Shinto
    Mitten, Ethna
    Ryan, Aisling
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1000 - 1001
  • [26] Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis
    Mark Sanford
    Drugs, 2014, 74 : 1411 - 1433
  • [27] Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis
    Sanford, Mark
    DRUGS, 2014, 74 (12) : 1411 - 1433
  • [28] Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
    Milanov, Ivan
    Ivanova, Sonya
    Tournev, Ivailo
    Chamova, Teodora
    Kaprelyan, Ara
    Slavov, Georgi
    Chervenkov, Vitan
    Kipriyanovska, Katerina
    REVISTA DE NEUROLOGIA, 2023, 77 : S1 - S7
  • [29] Regional efficacy of fingolimod in relapsing remitting multiple sclerosis
    Bogdan, I.
    Warren, C.
    Koniotes, A.
    Ruffer, G.
    Newell, B.
    Fisniku, L.
    Bremner, S.
    Gabel, M. C.
    Rashid, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 192 - 192
  • [30] Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis
    Thomas, Katja
    Proschmann, Undine
    Ziemssen, Tjalf
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1649 - 1660
12345